Tissue | Methodology | PMID |
---|---|---|
Testis | qRT-PCR | 19542363 |
Pancreas | qRT-PCR | 19542363 |
Stomach | qRT-PCR | 19542363 |
Liver | qRT-PCR | 19542363 |
Small intestine | qRT-PCR | 19542363 |
Bone marrow | qRT-PCR | 19542363 |
Adrenal gland | qRT-PCR | 19542363 |
Testis | Northern blot | 14614621 |
Testis | RT-PCR | 14614621 |
Testis | Dot-blot | 14614621 |
Pancreas | Dot-blot | 14614621 |
Ovary | RT-PCR | 14614621 |
Plasma cells | Microarray | 21738656 |
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Myeloma |
Newly diagnosed patient | 320/320 (100%) | Microarray | 21738656 |
Myeloma |
Relapse patient | 257/264 (97%) | Microarray |
Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Breast carcinoma | T47D MDA-MB-468 |
RT-PCR | 14614621 | |
Cervical carcinoma | HeLa | RT-PCR | 14614621 | |
Endometrial carcinoma | Ishikawa | RT-PCR | 14614621 | |
Hepatoma | HepG2 | RT-PCR | 14614621 | |
Ovarian carcinoma | PA1 | RT-PCR | 14614621 | |
Prostate carcinoma | LNCaP Du145 PC3 |
RT-PCR | 14614621 | |
Yolk sac carcinoma | 44M2 | RT-PCR | 14614621 |
2005-2009© CT Antigens Database